Effectiveness of subgaleal topical vancomycin powder in reducing infection rates and shunt revisions in pediatric ventriculoperitoneal shunt surgery: a promising prophylactic approach
Child's Nervous System · 2025
DOI: 10.1007/s00381-024-06672-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Child's Nervous System, 2025. Verfasst von Ece Uysal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Prof. Dr. Cemil Tascioglu City Hospital, University of Health Sciences, Istanbul, Turkey. dr.eceuysal.nrs@gmail.com. Hauptthemen laut MEDLINE: Vancomycin, Ventriculoperitoneal Shunt, Surgical Wound Infection, Anti-Bacterial Agents. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: This study aims to evaluate the effectiveness of two prophylactic strategies in preventing shunt infections in pediatric patients undergoing ventriculoperitoneal shunt surgery. METHODS: This retrospective study included pediatric patients who underwent ventriculoperitoneal shunt surgery between 2017 and 2024. Patients were divided into two groups based on the prophylactic method used: Group 1 (VS) where the shunt was washed with vancomycin solution before placement, and Group 2 (TVP) where vancomycin powder was applied to the subgaleal and subcutaneous tissues after shunt placement. Data collected included age, gender, preoperative CRP values, operation length, hospitalization duration, wound site problems, and rates of early (within 3 days) and late (within 36 months) postoperative infections and shunt revisions. RESULTS: Data from 56 pediatric patients were analyzed. The TVP group had significantly lower rates of early postoperative infections compared to the VS group (3.3% vs. 26.9%, p < 0.05). Late postoperative infections were also lower in the TVP group (3.3% vs. 30.7%, p < 0.05). Shunt revision was required in 26.9% of patients in the VS group, but none in the TVP group (p < 0.05). Wound site problems were a critical factor, with all patients experiencing wound site infections also developing early postoperative infections (p < 0.05). CONCLUSION: The use of subgaleal topical vancomycin powder is a promising prophylactic method in ventriculoperitoneal shunt surgery, particularly for pediatric patients who are prone to skin problems, as it effectively avoids systemic toxic effects while reducing infection rates and the need for shunt revisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Prof. Dr. Cemil Tascioglu City Hospital, University of Health Sciences, Istanbul, Turkey. dr.eceuysal.nrs@gmail.com.
- Prof. Dr. Suleyman Yalcin City Hospital, Istanbul Medeniyet University, Istanbul, Turkey.
- Van Training and Research Hospital, Van, Turkey.
Zitieren
APA
Uysal, E., Cine, H. S., & Cakaloglu, H. C. (2025). Effectiveness of subgaleal topical vancomycin powder in reducing infection rates and shunt revisions in pediatric ventriculoperitoneal shunt surgery: a promising prophylactic approach. Child's Nervous System. https://doi.org/10.1007/s00381-024-06672-6
Vancouver
Uysal E, Cine HS, Cakaloglu HC. Effectiveness of subgaleal topical vancomycin powder in reducing infection rates and shunt revisions in pediatric ventriculoperitoneal shunt surgery: a promising prophylactic approach. Child's Nervous System. 2025. doi:10.1007/s00381-024-06672-6
BibTeX
@article{Uysal2025,
author = {Uysal, Ece and Cine, Hidayet Safak and Cakaloglu, Haluk Cem},
title = {Effectiveness of subgaleal topical vancomycin powder in reducing infection rates and shunt revisions in pediatric ventriculoperitoneal shunt surgery: a promising prophylactic approach},
journal = {Child's Nervous System},
year = {2025},
doi = {10.1007/s00381-024-06672-6}
}
EUVIMED